Back to Infectious Disease
Infectious Diseasev2007Evidence-Based

HIV Needle Stick Risk Assessment Stratification Protocol (RASP)

Quantifies HIV exposure risk by source and exposure type to guide post-exposure prophylaxis (PEP) decisions following needle stick injuries or other potential HIV exposures.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
hiv risk
—risk_ratio
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The HIV Needle Stick Risk Assessment Stratification Protocol (RASP) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within infectious disease.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Basic risk = 1 / (Source population × Inoculum type × Method of transmission); Total risk (1 in X) = Basic risk × Volume of inoculum

Clinical Pearls & Practice Notes

  • PEP should be initiated as soon as possible, ideally within 2 hours of exposure
  • PEP can be considered up to 72 hours post-exposure but effectiveness decreases with time
  • Source population high-risk factors include: injection drug use, men who have sex with men, commercial sex work
  • High-risk fluids include: semen, vaginal secretions, CSF, synovial fluid, pleural fluid, peritoneal fluid, pericardial fluid, amniotic fluid
  • Low-risk secretions include: tears, urine, saliva, vomitus, feces (unless visibly bloody)
  • Standard PEP regimen is typically a 3-drug antiretroviral combination for 28 days

Evidence & Literature Citations

  1. Vertesi L. Risk Assessment Stratification Protocol (RASP) to help patients decide on the use of postexposure prophylaxis for HIV exposure. CJEM. 2003 Jan;5(1):46-8.
  2. Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS; U.S. Public Health Service. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. 2005 Sep 30;54(RR-9):1-17.
  3. Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med. 1997 Nov 20;337(21):1485-90.

Score Interpretation Ranges

Definitely Indicated0 – 1000 pts

Risk ≥1/1000

Recommended1001 – 10000 pts

Risk 1/1001-1/10000

Optional10001 – 100000 pts

Risk 1/10001-1/100000

Not Indicated100001 – 999999999 pts

Risk ≤1/100000

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.